SEC Form 4 · accession 0001209191-16-109211
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Toshinari Tamura
Director
Period of report
Mar 16, 2016
Accepted (ET)
Mar 17, 2016 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2016 | M | 24,000 | $2.35 | A | 24,000 | D | |
| Common Stock | Mar 16, 2016 | M | 12,000 | $2.90 | A | 36,000 | D | |
| Common Stock | Mar 16, 2016 | M | 12,000 | $2.90 | A | 48,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.35 | Mar 16, 2016 | M | 24,000 | D | — | Sep 10, 2018 | Common Stock | 24,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $2.90 | Mar 16, 2016 | M | 12,000 | D | — | Jun 9, 2020 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $2.90 | Mar 16, 2016 | M | 12,000 | D | — | Jun 24, 2020 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Fully vested.